Janin Kaper

Janin Kaper is a Field Application Scientist at MaxCyte, Inc. since October 2024, specializing in the Nordics and BeNeLux regions. Prior to this role, Kaper was a Field Application Specialist focused on Cell Therapy at ScaleReady, providing technical sales and support for B2B clients in the cell and gene therapy sector. Kaper has experience as the Head of GMP-lab at Radiumhemmets Forskningsfonder, developing Advanced Medicinal Therapy Products for cancer treatment, and as a Scientist and Bioengineer at Anocca AB, concentrating on TCR T-cell therapies. Early career experience includes an internship in toxicology at LaborBerlin and a Laboratory Research Assistant position at the Institut für Neurogenetik, Universität zu Lübeck. Kaper holds a Master of Science in Toxicology from Karolinska Institutet and a Bachelor of Science in Molecular Life Sciences from Universität zu Lübeck, along with a qualification as a Medical Laboratory Technologist from Germany.